Panacea Life Sciences Holdings, Inc.
Panacea Life Sciences Holdings, Inc. (PLSH) Revenue
Annual & quarterly revenue history · segment & region breakdown
PLSH · revenue · updated Jun 15, 2026
Core revenue metrics
Trailing 12 monthsPanacea Life Sciences Holdings, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 77.83% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2015 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | -$0.00B | -77.83% |
| 2024-12-31 | $0.00B | +$0.00B | +72.23% |
| 2023-12-31 | $0.00B | +$0.00B | +46.59% |
| 2022-12-31 | $0.00B | -$0.00B | -21.01% |
| 2021-12-31 | $0.00B | -$0.01B | -77.16% |
| 2020-12-31 | $0.01B | +$0.01B | +2508.69% |
| 2019-12-31 | $0.00B | +$0.00B | — |
| 2018-12-31 | $0.00B | +$0.00B | — |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | -$0.00B | -100.00% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Panacea Life Sciences Holdings, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Panacea Life Sciences Holdings, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Panacea Life Sciences Holdings, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PLSH revenue · 4 questionsPLSH's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 77.83% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Panacea Life Sciences Holdings, Inc. SEC filings · GAAP · Panacea Life Sciences Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026